KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biolife Solutions (BLFS) Amortization - Intangibles (2016 - 2025)

Biolife Solutions (BLFS) has disclosed Amortization - Intangibles for 9 consecutive years, with -$1.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Amortization - Intangibles rose 24.66% to -$1.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $263000.0, a 258.43% increase, with the full-year FY2025 number at $263000.0, changed 0.0% from a year prior.
  • Amortization - Intangibles was -$1.8 million for Q4 2025 at Biolife Solutions, down from $699000.0 in the prior quarter.
  • In the past five years, Amortization - Intangibles ranged from a high of $2.9 million in Q1 2022 to a low of -$4.2 million in Q4 2022.
  • A 5-year average of $680850.0 and a median of $916500.0 in 2021 define the central range for Amortization - Intangibles.
  • Peak YoY movement for Amortization - Intangibles: soared 257.65% in 2021, then crashed 245.17% in 2022.
  • Biolife Solutions' Amortization - Intangibles stood at $2.9 million in 2021, then crashed by 245.17% to -$4.2 million in 2022, then grew by 27.13% to -$3.1 million in 2023, then rose by 20.57% to -$2.4 million in 2024, then rose by 24.66% to -$1.8 million in 2025.
  • Per Business Quant, the three most recent readings for BLFS's Amortization - Intangibles are -$1.8 million (Q4 2025), $699000.0 (Q3 2025), and $698000.0 (Q2 2025).